Kymera Therapeutics Net Foreign Currency Exchange Gain/Loss (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

85.68 -4.00 (-4.46%) USD | NASDAQ | Dec 15, 16:00

85.68 0.00 (0.00%) Pre-Market: 09:27

View Net Foreign Currency Exchange Gain/Loss (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Foreign Currency Exchange Gain/Loss (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Sanofi	--
Cytokinetics, Inc.	--
TG Therapeutics, Inc.	--